Observed HIV drug resistance associated mutations amongst naïve immunocompetent children in Yaounde, Cameroon
dc.contributor.author | Ikomey, George Mondinde | en_ZA |
dc.contributor.author | Assoumou, Marie Claire Okomo | en_ZA |
dc.contributor.author | Gichana, Josiah Otwoma | en_ZA |
dc.contributor.author | Njenda, Duncan | en_ZA |
dc.contributor.author | Mikasi, Sello Given | en_ZA |
dc.contributor.author | Mesembe, Martha | en_ZA |
dc.contributor.author | Lyonga, Emilia | en_ZA |
dc.contributor.author | Jacobs, Graeme Brendon | en_ZA |
dc.date.accessioned | 2018-08-29T06:32:21Z | |
dc.date.available | 2018-08-29T06:32:21Z | |
dc.date.issued | 2017 | |
dc.description | CITATION: Ikomey, G. M., et al. 2017. Observed HIV drug resistance associated mutations amongst naïve immunocompetent children in Yaounde, Cameroon. GERMS, 7(4):178-185, doi:10.18683/germs.2017.1124. | |
dc.description | The original publication is available at http://www.germs.ro/en/Homepage/ | |
dc.description.abstract | Introduction: The emergence of drug resistance mutations (DRMs) has been a major threat for successful lifelong combination antiretroviral therapy (cART), especially for HIV-vertically infected children within the context of the prevention of mother-to-child transmission (PMTCT). This study aimed to evaluate DRMs amongst immune competent treatment-naïve children in Cameroon. Methods: A cross-sectional study was conducted between 2015 and 2016 amongst 55 proxy consented HIV-1 positive children, aged 9 months to 6 years. They were all immune competent, cART naïve and with unknown history of PMTCT. CD4 cell counts and genotypic drug resistance testing were performed using standard methods. Results: Levels of DRMs to protease (PR) inhibitors (PIs), nucleoside reverse transcriptase inhibitors (NRTIs) and non-NRTIs were 27.6%, 3.7% and 40.7%, respectively. Only minor DRMs were observed for PR. The observed mutations for NRTI were K65R, T215I and K219E (33.0% each) and for NNRTI: V106M, Y181C and Y188H (6.0% each). Only minor accessory mutations were found in the integrase (IN) region. Conclusion: Despite widely available cART we still observe naïve HIV children, especially from the rural communities. We observe that a proportion of study participants had HIV-1 drug resistance associated mutations (RAMs). Data generated could help strengthen the current PMTCT programmes within the country. There is a need to upscale approaches for drug resistance testing for children in Cameroon and many other resource-limited settings. | en_ZA |
dc.description.uri | http://www.germs.ro/en/Articles/Observed-HIV-drug-resistance-associated-mutations-amongst-na%C3%AFve-immunocompetent-children-in-Yaound%C3%A9-Cameroon-702 | |
dc.description.version | Publisher's version | |
dc.format.extent | 8 pages | |
dc.identifier.citation | Ikomey, G. M., et al. 2017. Observed HIV drug resistance associated mutations amongst naïve immunocompetent children in Yaounde, Cameroon. GERMS, 7(4):178-185, doi:10.18683/germs.2017.1124 | |
dc.identifier.issn | 2248-2997 (online) | |
dc.identifier.other | doi:10.18683/germs.2017.1124 | |
dc.identifier.uri | http://hdl.handle.net/10019.1/104360 | |
dc.language.iso | en_ZA | en_ZA |
dc.publisher | European HIV/AIDS and Infectious Diseases Academy | |
dc.rights.holder | European HIV/AIDS and Infectious Diseases Academy | |
dc.subject | Highly active antiretroviral therapy | en_ZA |
dc.subject | HIV-positive children | en_ZA |
dc.title | Observed HIV drug resistance associated mutations amongst naïve immunocompetent children in Yaounde, Cameroon | en_ZA |
dc.type | Article | en_ZA |